Penang to meet vape industry before deciding on possible sales ban
Chief Minister Chow Kon Yeow said the state government had received a letter from representatives of the vape industry regarding the matter.
"They wanted us to hear them out, and we are prepared to do so.
"I have instructed the relevant state executive council member to meet with them and listen to their concerns," he told reporters today, adding that the letter was received recently.
Last month, State Health Committee chairman Daniel Gooi told the state legislative assembly that Penang might consider imposing a statewide ban on the sale of vape products next year if enforcement under the new smoking control law proves ineffective.
The Control of Smoking Products for Public Health Act 2024 (Act 852), which came into force on Oct 1 last year, aims to strengthen regulations on the sale, advertising, and promotion of all smoking products, including e-cigarettes and vape, across Malaysia.
The Act specifically targets individuals under the age of 18, prohibiting them from selling, purchasing or using any smoking product by any means.
Chow added that Penang was not the only state considering a statewide ban on the sale of vape products.
He said several other states were also exploring the same move.
"Of course, we are aware of the health risks associated with the irresponsible use of vape products.
"However, there are other issues we need to consider. Imposing a ban will have various consequences and may not effectively address the social problems related to the underground sale of vape products.
"As such, we need to study the matter carefully before making any decision," he added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
5 hours ago
- The Star
Singapore public healthcare institutions to record all Kpod cases, confiscate vapes
FILE PHOTO: Electronic vape seized at Custom Cargo KLIA Complex in Sepang on June 19, 2025.–AZMAN GHANI/The Star SINGAPORE: Public healthcare institutions have been told to record all suspected and confirmed etomidate-linked vaping cases, in a sign that the health authorities are treating vapes laced with etomidate more seriously. In a circular dated July 9, the Ministry of Health (MOH) and Health Sciences Authority (HSA) said medical practitioners should also get patients to surrender their e-vapourisers and consider sending their urine samples for testing. This is because both authorities noticed a worrying increase in the number of e-vapoUrisers detected containing etomidate in Singapore between 2024 and 2025. Such devices are also known as 'Kpods', which the authorities have recently intensified crackdowns on. The circular highlighted the report in March by the United Nations Office on Drugs and Crime, which said etomidate had been notably detected in illicit drug markets in East and South-East Asia. Etomidate is a medicinal ingredient used in clinical practice as an anaesthetic agent and is classified as a poison under the Poisons Act. This means a licence is required for its importation or sale. Etomidate found in vapes or supplied in oil capsules or formulations to be inhaled directly into users' lungs are not medical products and are prohibited. Under the Act, those found in possession of or using pods containing etomidate can be jailed for up to two years, fined up to S$10,000 (US$7,798), or both. MOH and HSA said that because of the rising concerns, they are studying the harm and addictiveness of etomidate use in vapes, through those who seek medical attention. These studies will inform and shape policy, including whether existing regulations need to be tightened or amended. On July 12, MOH and the Ministry of Home Affairs said they were considering further steps to better address the vaping issue, including whether current laws for enforcement could be enhanced. The number of cases involving etomidate-laced vape pods has nearly tripled in Singapore to 28 cases in the first six months of 2025, compared with ten in the whole of 2024. The MOH-HSA circular was addressed to emergency departments, urgent care centres, departments of psychiatry of public healthcare institutions, and the National Addictions Management Service Centre at the Institute of Mental Health. In it, the authorities said medical practitioners should reassure patients that enforcement actions will not be taken against them for previous vape use if they voluntarily come forward to seek medical help. Medical practitioners were told to observe symptoms and signs like seizures, dizziness, confusion, slurred speech, coughing, arrhythmias and thermal injury to airways. In the circular, the authorities invoked powers under the Healthcare Services Act, requiring licensed medical practitioners to comply with the instructions. Those who fail to do so can be jailed for up to a year and fined up to S$10,000. During medical consultation, medical practitioners should confiscate the vapes, place them in ziplock bags and lock them up. They should also consider sending patients' urine samples to HSA for toxicology testing. MOH and HSA said members of the public who have sought assistance through the Health Promotion Board's QuitLine may be directed to seek medical help at public health institutions' emergency departments. After treatment, these emergency departments may refer patients to the QuitLine on 1800-438-2000 for continued support. Participants of HPB's I Quit programme need not worry about being fined or prosecuted, as it does not presume they have or use vaping products. But if they are caught using or possessing such items, then they will be prosecuted. MOH and HSA previously said more than S$41 million worth of vapes and related components were seized between January 2024 and March 2025. More than 14,600 people were caught by the authorities in 2024, compared with 4,916 in 2022. - The Straits Times/ANN
Malaysiakini
8 hours ago
- Malaysiakini
Rakan KKM public or private initiative?
MP SPEAKS | Strictly, the question of whether an initiative or entity is public or private comes down to questions on ownership, control, sources of funding, distribution of profits, and purpose. Rakan KKM Sdn Bhd is 100 percent owned by the Minister of Finance Incorporated (MOF Inc). When a government-linked investment company (GLIC) investor comes in, the GLIC may take an equity stake in Rakan KKM Sdn Bhd. Ownership of Rakan KKM remains with the government, directly or through GLICs, throughout its operations. As for control, the Health Ministry is the "kementerian kawal selia" responsible for critical decisions over the management of the company. Seed funding of RM25 million from the Finance Ministry was announced in the budget. Additional scale-up funding from GLICs will be explored in Phase 2, which will be repaid through the revenues/profits of Rakan KKM operations. In all cases, sources of financing remain government or government-linked. Profit distribution is to the shareholders/owners of Rakan KKM - ie MOF Inc or GLICs. Rakan KKM's purpose As a public initiative, Rakan KKM serves five key objectives which are in the public interest: (a) In the environment of high medical price inflation, Rakan KKM provides premium economy value-based healthcare services to raise the ceiling, (b) Excess revenue from Rakan KKM will be used to cross-subsidise the services for all public patients, thus raising the floor, (c) Support the retention of ministry health workers by providing opportunities to increase their income considerably, (d) Serve as a price benchmark, including for services provided by private hospitals, to moderate medical price inflation for all, including patients who do not directly use Rakan KKM services, and (e) Provide appropriate returns for our GLIC shareholders and their members. Act 586 But why is Rakan KKM licensed under the Private Healthcare Facilities and Services Act 1998 (Act 586)? Does that make it a private initiative? The experts who drafted Act 586 had the foresight to anticipate the possibility that the government would provide health services through a corporate body. This is important to ensure a level playing field with the private sector, especially if Rakan KKM is to play a role as a price benchmark. The Act clearly states that a government corporate body should be regulated under this Act. DZULKEFLY AHMAD is Kuala Selangor MP and health minister. The views expressed here are those of the author/contributor and do not necessarily represent the views of Malaysiakini.
The Star
a day ago
- The Star
Rakan KKM not privatisation, says Health Minister
KUALA LUMPUR: The recently announced Rakan KKM initiative is not a form of healthcare privatisation, says Health Minister Datuk Seri Dr Dzulkefly Ahmad. He said that it is a government-owned and controlled public initiative designed to support and complement the existing healthcare system. In a post on X (formerly known as Twitter) on Monday (July 14), Dzulkefly addressed concerns from various quarters that feared that the incorporation of Rakan KKM Sdn Bhd signalled a move towards the privatisation of public health services. 'For those who have tagged me with their concerns, I hope the following clarification resolves this conclusively although I have my anxieties or doubts, especially at a time when many are only keen to read headlines,' he said. He explained that Rakan KKM Sdn Bhd is 100% owned by the Minister of Finance Incorporated (MoF Inc). 'Ownership of Rakan KKM remains with the government, directly or through GLICs, throughout its operations,' said Dzulkefly. He said that ownership would still remain within the government's framework even when government-linked investment companies (GLICs) become involved later through equity stakes. Dzulkefly added that the Health Ministry is the regulatory authority overseeing critical decisions related to Rakan KKM. He then said that its funding is entirely from public sources, with RM25mil seed funding provided by the Finance Ministry, and potential scale-up funding from GLICs in Phase 2. As for profit distribution, Dzulkefly said that it would go back to the government or GLICs and not private individuals and added that any excess revenue would be used to cross-subsidise services for all public patients. He said that Rakan KKM was established to achieve five key public-interest goals; to provide value-based, premium economy healthcare in response to rising medical costs, to subsidise care for public patients using excess revenue, and to support ministry healthcare workers by offering them additional income opportunities. It also aims to serve as a benchmark for healthcare pricing to moderate inflation, and to offer returns to government-linked shareholders, ensuring the initiative's long-term sustainability. Dzulkefly also addressed questions regarding why Rakan KKM is licensed under the Private Healthcare Facilities and Services Act 1998 (Act 586), often associated with private entities. He explained that the law was designed to accommodate government corporate bodies providing healthcare services, ensuring a level playing field when they operate alongside private hospitals. 'This is important to ensure a level playing field with the private sector, especially if Rakan KKM is to play a role as a price benchmark,' he said. He added that the Act clearly distinguishes incorporated government healthcare providers from privatised ones. Dzulkefly also acknowledged the complexity of the subject and pledged to explain it further through infographics in the near future to ensure better public understanding.
